Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.
Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. · 2013
Read Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. by Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3569654.txt.
Description
Jenny Henkel and colleagues linked a class of immune cells to the speed of ALS in EMBO Molecular Medicine in 2013. Amyotrophic lateral sclerosis kills motor neurons, but patients decline at very different rates. Regulatory T-lymphocytes, or Tregs, calm immune responses, and in mice they slow this disease. The group asked whether Treg levels in patients track how fast their disease moves.
Blood tests showed fewer Tregs and less of their key protein, FoxP3, in fast-progressing patients, and the lower the levels, the faster the decline. Messages for FoxP3 and for partner immune signals fell in the same pattern, and two of them flagged progression accurately. In a second, larger group followed for three and a half years, low FoxP3 early on predicted rapid decline and shorter survival. The marker could help doctors spot fast cases early and plan trials.
Catalog record
| CREATOR | Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |